Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.


Hydroxychloroquine fails to significantly improve COVID-19 survival rates, studies show


Most these trials are conducted in patients already hospitalised. If Chloroquine had any antiviral activity at all, it would only likely be beneficial in the early stages of the disease, as a preventive. Once the virus has already replicated and become established, there's very little any antiviral could do.

Posted date

22 MAY 2020

Posted time



Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.